Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.
- The HTLV-I Tax oncoprotein: hyper-tasking at the molecular levelDiane R. Wycuff, Susan J. MarriottFront. Biosci. (Landmark Ed) 2005, 10(1), 620–642; https://doi.org/10.2741/15582Download14Citations11Views
- Setting the stage for transformation: HTLV-1 Tax inhibition of p53 functionCynthia A. Pise-Masison, John N. BradyFront. Biosci. (Landmark Ed) 2005, 10(1), 919–930; https://doi.org/10.2741/15865Download23Citations47Views
- The human T-cell leukemia virus Rex proteinIhab Younis, Patrick L. GreenFront. Biosci. (Landmark Ed) 2005, 10(1), 431–445; https://doi.org/10.2741/15394Download49Citations9Views
- Infectious transmission and replication of human T-cell leukemia virus type 1David Derse, Gisela Heidecker, Michael Mitchell, Shawn Hill, ... Gerald PrinclerFront. Biosci. (Landmark Ed) 2004, 9(4), 2495–2499; https://doi.org/10.2741/14119Download16Citations8Views
- Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approachesNorihiro Takenouchi, Karen Yao, Steven JacobsonFront. Biosci. (Landmark Ed) 2004, 9(4), 2527–2539; https://doi.org/10.2741/14142Download11Citations6Views
- Paradoxical effects of DNA binding polyamides on HTLV-1 transcriptionJill A Livengood, Eric J Fechter, Peter B Dervan, Jennifer K NyborgFront. Biosci. (Landmark Ed) 2004, 9(5), 3058–3067; https://doi.org/10.2741/14593Download5Citations8Views
- HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection?Nicolas Manel, Naomi Taylor, Sandrina Kinet, Felix J Kim, ... Marc SitbonFront. Biosci. (Landmark Ed) 2004, 9(6), 3218–3241; https://doi.org/10.2741/147410Download10Citations5Views
- Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expressionMichael Bindhu, Amrithraj Nair, Michael D LairmoreFront. Biosci. (Landmark Ed) 2004, 9(4), 2556–2576; https://doi.org/10.2741/14171Download22Citations4Views